[Forschungsbericht]Der Markt für männliche Unfruchtbarkeit wird bis 2027 voraussichtlich 6.213,96 Millionen US-Dollar erreichen, gegenüber 3.883,82 Millionen US-Dollar im Jahr 2019; Von 2020 bis 2027 wird ein durchschnittliches jährliches Wachstum von 6,2 % erwartet.
Faktoren wie die weltweite Zunahme der männlichen Unfruchtbarkeit und technologische Fortschritte treiben das Marktwachstum voran. Allerdings behindern die hohen Verfahrenskosten das Wachstum des Marktes für männliche Unfruchtbarkeit.
Lukrative regionale Märkte für männliche Unfruchtbarkeit
Markteinblicke
Steigerung der männlichen Fruchtbarkeit weltweit
Unfruchtbarkeit bei Männern ist ein globales Problem, wobei die Prävalenzprozentsätze von Region zu Region unterschiedlich sind. Samenmangel und schlechte Samenqualität sind die Hauptursachen für Unfruchtbarkeit bei Männern. Nach Angaben der National Institutes of Health (NIH) waren im Jahr 2016 etwa 15 % der Paare weltweit von Unfruchtbarkeit betroffen, d Die Rate unter Männern war in Afrika und Ost-/Mitteleuropa am höchsten. Nach Angaben der Weltgesundheitsorganisation (WHO) liegt das Problem bei etwa 20 % der unfruchtbaren Paare beim männlichen Partner, während bei 30 % der Paare das Problem bei beiden Partnern auftritt. Somit sind Männer weltweit für etwa 50 % aller Unfruchtbarkeitsfälle verantwortlich. Darüber hinaus produziert laut Healthy Male Andrology Australia, einer vom australischen Gesundheitsministerium finanzierten Abteilung, etwa einer von 20 Männern eine geringe Anzahl an Spermien, was zu Unfruchtbarkeit führt, und einer von etwa 100 Männern hat überhaupt keine Spermien.
Zu den häufigsten Faktoren, die für die Unfruchtbarkeit bei Männern verantwortlich sind, gehören eine niedrige Hormonproduktion in der Hypophyse, sexuelle Probleme, die den Eintritt von Samen in den Vaginaltrakt beeinträchtigen, und das Vorhandensein von Spermienantikörpern. Varikozele, also das Vorhandensein erweiterter Venen im Hoden, ist die häufigste Ursache für eine niedrige Spermienzahl bei Männern. Nach Angaben des US-Gesundheitsministeriums kommt es bei etwa 40 % der Männer, die unter Unfruchtbarkeitsproblemen leiden, zu einer Varikozele.
Daher führt die erschreckende Prävalenz männlicher Unfruchtbarkeit zu einer größeren Nachfrage nach Behandlungen und Dienstleistungen für männliche Unfruchtbarkeit .
Testbasierte Erkenntnisse
Der globale Markt für männliche Unfruchtbarkeit ist, basierend auf Tests, in DNA-Fragmentierungstechnik, oxidative Stressanalyse, computergestützte Samenanalyse, mikroskopische Untersuchung, Spermienagglutination, Spermienpenetrationstest und andere. Das Segment DNA-Fragmentierungstechnik hielt 2019 den größten Marktanteil; während erwartet wird, dass das Segment der computergestützten Samenanalyse im Prognosezeitraum die höchste CAGR auf dem Markt verzeichnen wird.
Globaler Markt für männliche Unfruchtbarkeit, nach Tests 2019 und 2027
Behandlungstyp- Basierende Erkenntnisse
Der Markt für männliche Unfruchtbarkeit ist je nach Behandlungsart in assistierte Reproduktionstechnologie und Varikozelenchirurgie sowie Medikamente unterteilt. Das Segment der assistierten Reproduktionstechnologie und der Varikozelenchirurgie hielt 2019 einen größeren Marktanteil und wird voraussichtlich im Prognosezeitraum eine höhere CAGR auf dem Markt verzeichnen.
Einblicke auf der Grundlage von Vertriebskanälen
< p>Der Markt für männliche Unfruchtbarkeit ist je nach Vertriebskanal in Krankenhausapotheken, Apotheken und Drogerien sowie Online-Apotheken unterteilt. Im Jahr 2019 hielt das Segment Krankenhausapotheken den größten Marktanteil. Darüber hinaus wird geschätzt, dass der Markt für dasselbe Segment im Zeitraum 20202027 mit der höchsten CAGR wächst.
Endbenutzerbasierte Erkenntnisse
Der männliche Unfruchtbarkeitsmarkt, basierend auf Endbenutzern, ist in Fruchtbarkeitszentren, Krankenhäuser und Kliniken, Forschungsinstitute und andere Endverbraucher unterteilt. Im Jahr 2019 hielt das Segment Fruchtbarkeitszentren den größten Marktanteil. Darüber hinaus wird erwartet, dass dasselbe Segment von 2020 bis 2027 die höchste CAGR von 6,8 % auf dem Markt verzeichnen wird.
Strategische Einblicke
Unternehmen wie Vitrolife und Halotech DNA haben mehrere anorganische Produkte eingeführt und organische Strategien zur Verbesserung ihres Umsatzes und ihrer Position auf dem Markt für männliche Unfruchtbarkeit. Die engagierten Leistungen wichtiger Akteure haben zur Verfügbarkeit besserer Dienstleistungen und Produkte auf dem Markt geführt.
Markt für männliche Unfruchtbarkeit durch Test
- DNA-Fragmentierungstechnik
- Analyse des oxidativen Stresses
- Mikroskopische Untersuchung
- Sperma-Agglutination
- Computergestützte Samenanalyse
- Sperma-Penetrationstest
< li>Andere
Markt für männliche Unfruchtbarkeit nach Behandlungstyp
- Assistierte Reproduktionstechnologie
- In-vitro-Fertilisation (IVF)
- Intrazytoplasmatische Spermieninjektion (ICSI)
- Varikozelenchirurgie
- Medikamente
Markt für männliche Unfruchtbarkeit nach Vertriebskanal
- Krankenhäuser, Apotheken
- Apotheken und Drogerien
- Online-Apotheken
Markt für männliche Unfruchtbarkeit nach Endbenutzer
- Krankenhäuser und Kliniken
- Fruchtbarkeitszentren
- Forschungsinstitute
- Andere Endbenutzer
- Nordamerika
- USA
- Kanada
- Mexiko
- Europa
- Deutschland
- Großbritannien
- Frankreich
- Italien
- Spanien
- Schweden
- Dänemark
- Polen
- Türkei
- Niederlande
- Belgien
- Finnland
- Schweiz
- Irland
- Norwegen
- Restliches Europa
- Asien-Pazifik (APAC)
- Japan
- China
- Indien
- Südkorea
- Australien
- Thailand
- Singapur
- Neuseeland
- Vietnam
- Übriger Asien-Pazifik
- Naher Osten und Afrika (MEA)
- VAE
- Saudi-Arabien
- Südafrika
- Ägypten
- Israel
- Übriger Naher Osten und Afrika
- Süd- und Mittelamerika (SCAM)
- Brasilien
- Argentinien
- Übriges Süd- und Mittelamerika
- MERCK KGaA
- Sanofi
- Bayer AG
- Endo Pharmaceuticals Inc.
- SCSA Diagnostics, Inc.
- Halotech DNA
- INTAS PHARMACEUTICALS LTD.
- Cadila Pharmaceuticals Ltd.
- Vitrolife
Markt für männliche Unfruchtbarkeit nach Geografie
Unternehmensprofile
< li>Andrology Solutions
Report Coverage
Revenue forecast, Company Analysis, Industry landscape, Growth factors, and Trends
Segment Covered
This text is related
to segments covered.
Regional Scope
North America, Europe, Asia Pacific, Middle East & Africa, South & Central America
Country Scope
This text is related
to country scope.
Frequently Asked Questions
Male infertility is due to low sperm production, abnormal sperm function or blockages that prevent the delivery of sperm. Illnesses, injuries, chronic health problems, lifestyle choices such as Smoking, drinking alcohol, and taking certain medications can lower sperm numbers. Other causes of low sperm numbers include long-term sickness (such as kidney failure), childhood infections (such as mumps), and chromosome or hormone problems (such as low testosterone). In over a third of infertility cases, the problem is with the man. This is most often due to problems with the sperm production or with sperm delivery.
The male infertility market is estimated to grow owing to key driving factors such as increasing infertility rate, rising adoption of assisted reproductive technologies (ART), and a shift towards sedentary lifestyle across the globe. However, high cost of the procedures is likely to hamper the growth of the market during the forecast period.
Global male infertility market is segmented by region into North America, Europe, Asia-Pacific, Middle East & Africa and South & Central America. In North America, the U.S. holds a significant share of the male infertility market. Innovations in the product line primarily drive the growth of the market in the country. The country focuses on changing the overall landscape and the best in the class healthcare infrastructure, advanced facilities, and awareness and openness amongst citizens towards the disease.The increasing infertility rate in the country is the primary factor driving growth during the study period. For instance, Infertility is a common problem, with more than 5 million couples in the United States dealing with these problems. It affects one in every six couples who are trying to conceive. In at least half of all cases of Infertility, a malefactor is a primary or contributing cause. This means that about 10% of all men in the United States attempting to conceive suffer from Infertility.
The List of Companies - Male Infertility Market
- MERCK KGaA
- Sanofi
- Bayer AG
- Endo Pharmaceuticals Inc.
- SCSA Diagnostics, Inc.
- Andrology Solutions
- Halotech DNA
- INTAS PHARMACEUTICALS LTD.
- Cadila Pharmaceuticals Ltd.
- Vitrolife.
The Insight Partners performs research in 4 major stages: Data Collection & Secondary Research, Primary Research, Data Analysis and Data Triangulation & Final Review.
- Data Collection and Secondary Research:
As a market research and consulting firm operating from a decade, we have published and advised several client across the globe. First step for any study will start with an assessment of currently available data and insights from existing reports. Further, historical and current market information is collected from Investor Presentations, Annual Reports, SEC Filings, etc., and other information related to company’s performance and market positioning are gathered from Paid Databases (Factiva, Hoovers, and Reuters) and various other publications available in public domain.
Several associations trade associates, technical forums, institutes, societies and organization are accessed to gain technical as well as market related insights through their publications such as research papers, blogs and press releases related to the studies are referred to get cues about the market. Further, white papers, journals, magazines, and other news articles published in last 3 years are scrutinized and analyzed to understand the current market trends.
- Primary Research:
The primarily interview analysis comprise of data obtained from industry participants interview and answers to survey questions gathered by in-house primary team.
For primary research, interviews are conducted with industry experts/CEOs/Marketing Managers/VPs/Subject Matter Experts from both demand and supply side to get a 360-degree view of the market. The primary team conducts several interviews based on the complexity of the markets to understand the various market trends and dynamics which makes research more credible and precise.
A typical research interview fulfils the following functions:
- Provides first-hand information on the market size, market trends, growth trends, competitive landscape, and outlook
- Validates and strengthens in-house secondary research findings
- Develops the analysis team’s expertise and market understanding
Primary research involves email interactions and telephone interviews for each market, category, segment, and sub-segment across geographies. The participants who typically take part in such a process include, but are not limited to:
- Industry participants: VPs, business development managers, market intelligence managers and national sales managers
- Outside experts: Valuation experts, research analysts and key opinion leaders specializing in the electronics and semiconductor industry.
Below is the breakup of our primary respondents by company, designation, and region:
Once we receive the confirmation from primary research sources or primary respondents, we finalize the base year market estimation and forecast the data as per the macroeconomic and microeconomic factors assessed during data collection.
- Data Analysis:
Once data is validated through both secondary as well as primary respondents, we finalize the market estimations by hypothesis formulation and factor analysis at regional and country level.
- Macro-Economic Factor Analysis:
We analyse macroeconomic indicators such the gross domestic product (GDP), increase in the demand for goods and services across industries, technological advancement, regional economic growth, governmental policies, the influence of COVID-19, PEST analysis, and other aspects. This analysis aids in setting benchmarks for various nations/regions and approximating market splits. Additionally, the general trend of the aforementioned components aid in determining the market's development possibilities.
- Country Level Data:
Various factors that are especially aligned to the country are taken into account to determine the market size for a certain area and country, including the presence of vendors, such as headquarters and offices, the country's GDP, demand patterns, and industry growth. To comprehend the market dynamics for the nation, a number of growth variables, inhibitors, application areas, and current market trends are researched. The aforementioned elements aid in determining the country's overall market's growth potential.
- Company Profile:
The “Table of Contents” is formulated by listing and analyzing more than 25 - 30 companies operating in the market ecosystem across geographies. However, we profile only 10 companies as a standard practice in our syndicate reports. These 10 companies comprise leading, emerging, and regional players. Nonetheless, our analysis is not restricted to the 10 listed companies, we also analyze other companies present in the market to develop a holistic view and understand the prevailing trends. The “Company Profiles” section in the report covers key facts, business description, products & services, financial information, SWOT analysis, and key developments. The financial information presented is extracted from the annual reports and official documents of the publicly listed companies. Upon collecting the information for the sections of respective companies, we verify them via various primary sources and then compile the data in respective company profiles. The company level information helps us in deriving the base number as well as in forecasting the market size.
- Developing Base Number:
Aggregation of sales statistics (2020-2022) and macro-economic factor, and other secondary and primary research insights are utilized to arrive at base number and related market shares for 2022. The data gaps are identified in this step and relevant market data is analyzed, collected from paid primary interviews or databases. On finalizing the base year market size, forecasts are developed on the basis of macro-economic, industry and market growth factors and company level analysis.
- Data Triangulation and Final Review:
The market findings and base year market size calculations are validated from supply as well as demand side. Demand side validations are based on macro-economic factor analysis and benchmarks for respective regions and countries. In case of supply side validations, revenues of major companies are estimated (in case not available) based on industry benchmark, approximate number of employees, product portfolio, and primary interviews revenues are gathered. Further revenue from target product/service segment is assessed to avoid overshooting of market statistics. In case of heavy deviations between supply and demand side values, all thes steps are repeated to achieve synchronization.
We follow an iterative model, wherein we share our research findings with Subject Matter Experts (SME’s) and Key Opinion Leaders (KOLs) until consensus view of the market is not formulated – this model negates any drastic deviation in the opinions of experts. Only validated and universally acceptable research findings are quoted in our reports.
We have important check points that we use to validate our research findings – which we call – data triangulation, where we validate the information, we generate from secondary sources with primary interviews and then we re-validate with our internal data bases and Subject matter experts. This comprehensive model enables us to deliver high quality, reliable data in shortest possible time.
Related Reports
Oct 2020
Bioprocessing Market
Size and Forecast (2021 - 2031), Global and Regional Share, Trend, and Growth Opportunity Analysis Report Coverage: By Product (Instruments, and Consumables and Accessories), Scale of Operation (Commercial Operations and Clinical Operations), Process (Downstream Bioprocess and Upstream Bioprocess), Application (Monoclonal Antibodies, Vaccines, Recombinant Protein, Cell and Gene Therapy, and Others), End User (Biopharmaceutical Companies, Contract Manufacturing Organization, and Others), and Geography (North America, Europe, Asia Pacific, South & Central America, and Middle East & Africa)
Oct 2020
Bioproduction Market
Size and Forecasts (2020 - 2030), Global and Regional Share, Trends, and Growth Opportunity Analysis Report Coverage: By Product (Biologics and Biosimilars, Vaccines, Cell and Gene Therapies, Nucleic Acid Therapeutics, and Others), Application (Rheumatoid Arthritis, Hematological Disorders, Cancer, Diabetes, Cardiovascular Diseases, and Others), Equipment (Upstream Equipment, Downstream Equipment, Bioreactors, and Consumables and Accessories), End User (Biopharmaceutical Companies, Contract Manufacturing Organizations, and Others), and Geography (North America, Europe, Asia Pacific, Middle East & Africa, and South & Central America)
Oct 2020
ELISA Diagnostic Test Market
Size and Forecasts (2020 - 2030), Global and Regional Share, Trends, and Growth Opportunity Analysis Report Coverage: By Adoption (Human and Veterinary), Test Type (Sandwich ELISA, Indirect ELISA, Competitive ELISA, and Multiple & Portable ELISA), Application (Autoimmune Diseases, Infectious Diseases, Cancer Diagnosis, Protein Quantification, and Others), End User (Hospitals & Diagnostic Centers, Pharmaceutical & Biotechnology Companies, Veterinary Hospitals & Diagnostic Laboratories, and Others), and Geography (North America, Europe, Asia Pacific, South & Central America, and Middle East & Africa)
Oct 2020
Swine Diagnostics Market
Size and Forecasts (2022 - 2030), Global and Regional Share, Trends, and Growth Opportunity Analysis Report Coverage: By Product Type [Immunoassays Kits, PCR Kits, Hemagglutination Inhibition (HI), and Others], Sample Type (Blood, Oral Fluids, Nasal Swabs, Tissue Samples, and Others), Disease [African Swine Fever (ASF)/Classical Swine Fever (CSF), Respiratory Diseases, Porcine Circovirus, Porcine Epidemic Diarrhea, Swine Dysentery, and Others], End User (Veterinary Hospitals, Veterinary Clinics, and Other End Users), and Geography
Oct 2020
Microbial Identification Methods Market
Size and Forecasts (2020 - 2030), Global and Regional Share, Trends, and Growth Opportunity Analysis Report Coverage: By Method (Genotypic, Phenotypic, and Proteotypic), Type (Bacterial Identification System, Microbial Enumeration System, Bacterial Resistance Identification Systems, Microbiology Analyzer, and Others), and Geography (North America, Europe, Asia Pacific, Middle East & Africa, and Latin America)
Oct 2020
Biopharmaceuticals Market
Forecast to 2028 - COVID-19 Impact and Global Analysis By Product Type (Monoclonal Antibodies, Recombinant Vaccines, Conventional Vaccines, Recombinant Growth Factors, Purified Proteins, Recombinant Proteins, Recombinant Hormones, Recombinant Enzymes, Cell & Gene Therapies, Cytokines/Interferon/Interleukins, and Others) and Application (Oncology, Inflammatory & Infectious Disease, Autoimmune Disorders, Metabolic Disorders, Hormonal Disorders & Growth Failure, Cardiovascular Diseases, Neurological Diseases, and Others)
Oct 2020
GMP Cell Therapy Consumables Market
Forecast to 2028 - COVID-19 Impact and Global Analysis by Product (Kits, Reagents/Molecular Biology Reagents, Growth Factors/Cytokines and Interleukins, and Others), Cell Therapy (NK Cell Therapy, Stem Cell Therapy, T-Cell Therapy, and Others), Process (Cell Collection and Characterization/Sorting and Separation, Cell Culture and Expansion/Preparation, Cryopreservation, Cell Processing and Formulation, Cell Isolation and Activation, Cell Distribution/Handling, Process Monitoring and Control/Readministration/Quality Assurance, and Others), and End Use (Clinical, Commercial, and Research)